Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Profit After Tax (2016 - 2025)

CorMedix (CRMD) has disclosed Profit After Tax for 14 consecutive years, with $108.6 million as the latest value for Q3 2025.

  • Quarterly Profit After Tax rose 4009.63% to $108.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $131.2 million through Dec 2025, up 831.93% year-over-year, with the annual reading at $1.7 million for FY2025, 109.48% up from the prior year.
  • Profit After Tax hit $108.6 million in Q3 2025 for CorMedix, up from $2.0 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $108.6 million in Q3 2025 to a low of -$14.5 million in Q1 2024.
  • Historically, Profit After Tax has averaged $1.3 million across 5 years, with a median of -$7.4 million in 2021.
  • Biggest five-year swings in Profit After Tax: tumbled 64.15% in 2022 and later soared 4009.63% in 2025.
  • Year by year, Profit After Tax stood at -$7.8 million in 2021, then fell by 5.34% to -$8.2 million in 2022, then decreased by 18.73% to -$9.7 million in 2023, then soared by 238.18% to $13.5 million in 2024, then soared by 706.3% to $108.6 million in 2025.
  • Business Quant data shows Profit After Tax for CRMD at $108.6 million in Q3 2025, $2.0 million in Q2 2025, and $20.6 million in Q1 2025.